Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed Jul 25, 2012 · 10-K · 86 days after period end · 0001354488-12-003634
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|
| Revenue | $95.49K | — |
| Net Income | -$2.61M | $2.85M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Apr 30, 2012 · filed Jul 25, 2012 · 86 d after period end
